一种考虑疫苗接种后突破性病毒感染两种时间机制的分析方法
针对疫苗接种后突破性感染,提出利用标准Cox比例风险框架的检验方法,以区分免疫衰减与新毒株出现两种时间机制。模拟研究显示该检验在不同设定下检测真实免疫衰减效应具有高功效和受控的I型错误,并评估了分析时间零点错分对偏倚和覆盖度的影响。
要点
- 提出Cox比例风险框架下的检验,用于区分免疫衰减与新毒株出现两种突破性感染机制。
- 模拟研究显示该检验在多种设定下检测真实免疫衰减效应具有强功效和受控的I型错误。
- 分析时间零点正确设定或校正时,估计偏倚减小且覆盖度提高。
核心结论
- 该检验在模拟研究中显示强功效和受控的I型错误,能检测不同设定下的真实免疫衰减效应。
- 分析时间零点正确设定或校正时,模型估计的偏倚减小且覆盖度提高。
研究设计与样本
- 研究提出利用标准Cox比例风险框架的检验,并通过模拟研究和真实世界数据示例应用评估其性能。
主要发现
- 模拟研究中,该检验在不同设定下检测真实免疫衰减效应具有强功效和受控的I型错误。
- 分析时间零点正确设定或校正时,估计偏倚减小且覆盖度提高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Real world data is an increasingly utilized resource for post-market monitoring of vaccines and provides insight into real world effectiveness. However, heterogeneous mechanisms may drive observed breakthrough infections among vaccinated individuals, such as waning vaccine-induced immunity or the emergence of a new strain against which the vaccine has reduced protection. Analyses of breakthrough infection incidence rates are typically predicated on a presumed temporal mechanism in their choice of an "analytic time zero" after which infection rates are modeled. In this work, we propose a test that utilizes a standard Cox proportional hazards framework to investigate two temporal mechanisms that can drive breakthrough infections of viral pathogens: waning immunity and the emergence of new strain. We explore the test's performance in simulation studies and in an illustrative application to real world data. We additionally introduce subgroup differences in infection incidence and evaluate the impact of time zero misspecification on bias and coverage of model estimates. In this study we observe strong power and controlled type I error of the test to detect true waning immunity effects under various settings. Similar to previous studies, we find mitigated bias and greater coverage of estimates when the analytic time zero is correctly specified or accounted for.
引用
- Brucker A, Hurst JH, O'Brien EC, et al. An analytic approach considering two temporal mechanisms driving breakthrough viral infections after vaccination. Vaccine. 2025. PMID: 40848677. doi:10.1016/j.vaccine.2025.127638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。